Glibenclamide/metformin

Glibenclamide/metformin
Combination of
Glibenclamide	Sulfonylurea
Metformin	Biguanide
Clinical data
Trade names	Glucovance
AHFS/Drugs.com	Monograph
MedlinePlus	a699055
License data	US DailyMed: Glyburide_and_metformin_hydrochloride;
Pregnancy; category	AU: C[1];
Routes of; administration	By mouth
ATC code	None;
Legal status
Legal status	AU: S4 (Prescription only) [1][2][3][4]; US: ℞-only [5];
Identifiers
CAS Number	338752-31-1;
KEGG	D10266;

Glibenclamide/metformin, also known as glyburide/metformin and sold under the brand name Glucovance, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes.[6] It contains glibenclamide, a sulfonylureas, and metformin, a biguanide.[7]

References

"TGA eBS - Product and Consumer Medicine Information Licence".
"Search the TGA website".
"Search the TGA website".
"Search the TGA website".
"Glucovance- glyburide and metformin hydrochloride tablet, film coated". DailyMed. 23 April 2012. Retrieved 30 April 2022.
Lamos EM, Stein SA, Davis SN (December 2012). "Combination of glibenclamide-metformin HCl for the treatment of type 2 diabetes mellitus". Expert Opinion on Pharmacotherapy. 13 (17): 2545–54. doi:10.1517/14656566.2012.738196. PMID 23116560. S2CID 10305382.
"Glyburide and metformin hydrochloride tablet". DailyMed. 10 June 2020. Retrieved 11 August 2020.

"Glyburide mixture with Metformin hydrochloride". Drug Information Portal. U.S. National Library of Medicine.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.